Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Frailty × Endocrine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 NET 1 Genitourinary 1 Endocrine 1

Conditions

Neuroendocrine Tumors 148 Carcinoma, Neuroendocrine 61 Thyroid Neoplasms 36 Carcinoid Tumor 35 Pheochromocytoma 34 Adrenocortical Carcinoma 33 Thyroid Carcinoma, Anaplastic 31 Thyroid Cancer, Papillary 27 Paraganglioma 27 Neoplasms 23 Adenoma, Islet Cell 23 Adenocarcinoma, Follicular 23 Neoplasm Metastasis 20 Somatostatinoma 19 Carcinoma, Medullary 19 Pancreatic Neoplasms 16 Insulinoma 15 Pituitary Neoplasms 14 Carcinoma, Islet Cell 14 Sarcoma 13 Glucagonoma 13 Gastro-enteropancreatic neuroendocrine tumor 13 Gastrinoma 13 Neuroblastoma 12 Colorectal Neoplasms 12 Small Cell Lung Carcinoma 11 Multiple Endocrine Neoplasia Type 1 11 Vipoma 10 Head and Neck Neoplasms 10 Carcinoma, Non-Small-Cell Lung 9

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05554003 2024-11-18

MeTe

European Institute of Oncology

Phase 2 Recruiting

Frailty, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡